scholarly article | Q13442814 |
P50 | author | Stephen C Strom | Q40919746 |
German Perdomo | Q47504458 | ||
Roberto Gramignoli | Q56395635 | ||
Hengjiang Dong | Q73409468 | ||
Sandra Slusher | Q114725745 | ||
Steven Ringquist | Q114725746 | ||
P2093 | author name string | Ting Zhang | |
Yong Fan | |||
Sojin Lee | |||
Dae Hyun Kim | |||
Nick Giannoukakis | |||
Brett E Phillips | |||
P2860 | cites work | Foxo1 mediates insulin action on apoC-III and triglyceride metabolism. | Q40301333 |
Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation- and 14-3-3-dependent and -independent mechanisms. | Q40609126 | ||
Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver | Q48386175 | ||
Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding | Q24306703 | ||
Structural basis for leucine-rich nuclear export signal recognition by CRM1 | Q24604395 | ||
Structural Basis for DNA Recognition by FoxO1 and Its Regulation by Posttranslational Modification | Q27652102 | ||
Crystal structure of the nuclear export receptor CRM1 in complex with Snurportin1 and RanGTP | Q27655147 | ||
FoxO6 transcriptional activity is regulated by Thr26 and Ser184, independent of nucleo-cytoplasmic shuttling | Q28258996 | ||
Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia | Q28365783 | ||
FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics | Q28504819 | ||
FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice | Q28507512 | ||
Cdc2-like kinase 2 is an insulin-regulated suppressor of hepatic gluconeogenesis | Q28511396 | ||
Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction | Q29619822 | ||
14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport | Q33292269 | ||
14-3-3 protein masks the DNA binding interface of forkhead transcription factor FOXO4. | Q33439373 | ||
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state | Q33968008 | ||
FoxOs function synergistically to promote glucose production | Q34284954 | ||
Effect of multiple phosphorylation events on the transcription factors FKHR, FKHRL1 and AFX. | Q34797172 | ||
FoxOs at the crossroads of cellular metabolism, differentiation, and transformation | Q35770614 | ||
14-3-3 proteins: a number of functions for a numbered protein | Q35841994 | ||
FoxO proteins in insulin action and metabolism | Q36110215 | ||
FoxO1 integrates insulin signaling to VLDL production | Q37148966 | ||
Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism | Q37149810 | ||
Overindulgence and metabolic syndrome: is FoxO1 a missing link? | Q38572199 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | gluconeogenesis | Q191835 |
preproinsulin | Q7240673 | ||
P304 | page(s) | 2763-2774 | |
P577 | publication date | 2011-09-22 | |
P1433 | published in | Diabetes | Q895262 |
P1476 | title | FoxO6 integrates insulin signaling with gluconeogenesis in the liver | |
P478 | volume | 60 |
Q37132127 | ATF4 protein deficiency protects against high fructose-induced hypertriglyceridemia in mice. |
Q35707124 | Acute Hepatic Insulin Resistance Contributes to Hyperglycemia in Rats Following Myocardial Infarction |
Q34049345 | CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis |
Q50290643 | Cardiac Development and Transcription Factors: Insulin Signalling, Insulin Resistance, and Intrauterine Nutritional Programming of Cardiovascular Disease |
Q37546947 | Cholesterol sulfate and cholesterol sulfotransferase inhibit gluconeogenesis by targeting hepatocyte nuclear factor 4α. |
Q51128779 | Crystal structures reveal a new and novel FoxO1 binding site within the human glucose-6-phosphatase catalytic subunit 1 gene promoter. |
Q90140626 | Current perspective on the regulation of FOXO4 and its role in disease progression |
Q34981792 | Deletion of hepatic FoxO1/3/4 genes in mice significantly impacts on glucose metabolism through downregulation of gluconeogenesis and upregulation of glycolysis |
Q55311614 | Dietary Flavonoids in the Prevention of T2D: An Overview. |
Q59135249 | Downregulation of FOXO6 in breast cancer promotes epithelial–mesenchymal transition and facilitates migration and proliferation of cancer cells |
Q33761863 | Elevated FOXO6 expression correlates with progression and prognosis in gastric cancer |
Q55285283 | Elevated hepatic expression of H19 long noncoding RNA contributes to diabetic hyperglycemia. |
Q26996783 | Energy metabolism in the liver |
Q36992902 | Expression of FOXO6 is Associated With Oxidative Stress Level and Predicts the Prognosis in Hepatocellular Cancer: A Comparative Study |
Q93387888 | FAM3B (PANDER) functions as a co-activator of FOXO1 to promote gluconeogenesis in hepatocytes |
Q39385262 | FOXO transcription factors at the interface of metabolism and cancer |
Q33594004 | FOXO transcription factors: their clinical significance and regulation. |
Q100235290 | FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes |
Q36065490 | FOXO1 mediates the autocrine effect of endothelin-1 on endothelial cell survival |
Q24293774 | FOXO6 promotes gastric cancer cell tumorigenicity via upregulation of C-myc |
Q35860656 | Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice. |
Q39141439 | FoxO integration of insulin signaling with glucose and lipid metabolism. |
Q36625105 | FoxO1 Plays an Important Role in Regulating β-Cell Compensation for Insulin Resistance in Male Mice. |
Q36925447 | FoxO6 and PGC-1α form a regulatory loop in myogenic cells |
Q36854236 | FoxO6 in glucose metabolism (FoxO6) |
Q99629124 | FoxO6 inhibits melanogenesis partly by elevating intracellular antioxidant capacity |
Q37648011 | FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver. |
Q28590430 | FoxO6 regulates memory consolidation and synaptic function |
Q51678237 | In vitro studies on the pleotropic antidiabetic effects of zinc oxide nanoparticles. |
Q33865096 | Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms |
Q50350755 | Involvement of the FOXO6 transcriptional factor in breast carcinogenesis. |
Q92579507 | Nanoformulations of natural products for management of metabolic syndrome |
Q54323656 | PKB/Akt phosphorylation of ERRγ contributes to insulin-mediated inhibition of hepatic gluconeogenesis. |
Q38058833 | Peripheral adrenoceptors: the impetus behind glucose dysregulation and insulin resistance. |
Q26799843 | Redox regulation of FoxO transcription factors |
Q35846190 | Salidroside ameliorates insulin resistance through activation of a mitochondria-associated AMPK/PI3K/Akt/GSK3β pathway. |
Q36544036 | Suppression of FoxO6 by lipopolysaccharide in aged rat liver |
Q38925481 | Targeting hepatic glucose metabolism in the treatment of type 2 diabetes |
Q34116131 | The essential role of FoxO6 phosphorylation in aging and calorie restriction |
Q38242060 | The roles of FoxOs in modulation of aging by calorie restriction |
Q36355517 | Transcriptional and Chromatin Regulation during Fasting - The Genomic Era |
Q33617037 | Transcriptional regulation of Caenorhabditis elegans FOXO/DAF-16 modulates lifespan. |
Q38077691 | Transcriptional regulators of hepatic gluconeogenesis. |
Q36348389 | Transcriptional regulatory logic of the diurnal cycle in the mouse liver |
Q36720498 | Yin Yang 1 promotes hepatic gluconeogenesis through upregulation of glucocorticoid receptor. |